Thiamine Treatment and Favorable Outcome in an Infant with Biallelic TPK1 Variants.
Matthias EckenweilerJohannes A MayrSarah GrünertAngela AbichtRudolf KorinthenbergPublished in: Neuropediatrics (2020)
Episodic encephalopathy due to mutations in the thiamine pyrophosphokinase 1 (TPK1) gene is a rare autosomal recessive metabolic disorder. Patients reported so far have onset in early childhood of acute encephalopathic episodes, which result in a progressive neurologic dysfunction including ataxia, dystonia, and spasticity. Here, we report the case of an infant with TPK1 deficiency (compound heterozygosity for two previously described pathogenic variants) presenting with two encephalopathic episodes and clinical stabilization under oral thiamine and biotin supplementation. In contrast to other reported cases, our patient showed an almost normal psychomotor development, which might be due to an early diagnosis and subsequent therapy.
Keyphrases
- copy number
- early onset
- end stage renal disease
- case report
- intellectual disability
- ejection fraction
- newly diagnosed
- spinal cord injury
- chronic kidney disease
- magnetic resonance
- liver failure
- prognostic factors
- oxidative stress
- patient reported outcomes
- replacement therapy
- peritoneal dialysis
- intensive care unit
- magnetic resonance imaging
- dna methylation
- mesenchymal stem cells
- transcription factor
- autism spectrum disorder
- cerebral palsy
- combination therapy
- aortic dissection